Skip to main content

Achelios Gets FDA Guidance on Approval Path for Migraine Drug

Achelios Therapeutics of Chapel Hill has completed a meeting with the U.S. Food and Drug Administration about a path to approval for its leading drug candidate, TOPOFEN, to treat acute and chronic migraine, a condition known for its debilitating pain.

New Companion Diagnostics Lab Extends Covance’s Precision Medicine Reach

Covance Drug Development, a global contract research organization that was acquired by Burlington-based LabCorp two years ago, has opened a new companion diagnostics laboratory in Morrisville to extend its capabilities in precision medicine.

Event Promotes NC Business, US Military Partnerships

One thing was clear, from the opening keynote to the final session, after a unique gathering of North Carolina business and Pentagon procurement leaders: the military is actively seeking private-sector partners to support the health and healing of U.S. warfighters and their families.

CivaTech’s Radiation Device Tested in First Pancreatic Cancer Patient

A Virginia man has become the first person in the world to be treated for pancreatic cancer with a bio-absorbable, implantable radiation device called CivaSheet, developed by Durham-based CivaTech Oncology.

 

Merz Reports Positive Test Results for Neurotoxin Drug

Merz Neurosciences, a division of Raleigh-based Merz North America, has reported positive results from a Phase 3 clinical trial of its drug Xeomin for the treatment of adult sialorrhea, or unwanted drooling, due to Parkinson’s disease and other neurologic disorders.

Bioventus Surgical Broadens Offerings with Big Healthcare Alliance

In a big win for its surgical business, Durham-based Bioventus says all of its surgical orthobiologics products are now available through Premier Inc., a large group purchasing organization consisting of 3,750 U.S. hospitals and more than 130,000 other healthcare providers.

Chiltern Acquires Japanese CRO for Greater Asian Presence

Chiltern, a global contract research organization (CRO) with U.S. headquarters in Wilmington, has acquired Integrated Development Associates Co. Ltd. (IDA), a Japanese CRO that specializes in integrating Japan and Asia into global drug development.

Grifols’ Zika Test Available for Blood Screening in Europe

A test for screening blood donations for presence of the Zika virus is now being sold in Europe by Grifols, a global developer of plasma-derived medicines that has 2,500 employees in North Carolina.

Pages

Subscribe to RSS - Business & Commercialization